ID: ALA2042692

Max Phase: Preclinical

Molecular Formula: C22H20F3N3O3

Molecular Weight: 431.41

Molecule Type: Small molecule

Representations

Canonical SMILES:  O=C(O)c1cc(CN2CCN(c3ccc(C(F)(F)F)cc3)CC2)c2ccccn2c1=O

Standard InChI:  InChI=1S/C22H20F3N3O3/c23-22(24,25)16-4-6-17(7-5-16)27-11-9-26(10-12-27)14-15-13-18(21(30)31)20(29)28-8-2-1-3-19(15)28/h1-8,13H,9-12,14H2,(H,30,31)

Standard InChI Key:  UFGBBVZMBLWLPS-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 431.41

Molecular Weight (Monoisotopic): 431.1457

AlogP: 3.34

#Rotatable Bonds: 4

Polar Surface Area: 65.26

Molecular Species: ACID

HBA: 5

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 3.47

CX Basic pKa: 7.86

CX LogP: 0.03

CX LogD: -0.07

Aromatic Rings: 3

Heavy Atoms: 31

QED Weighted: 0.69

Np Likeness Score: -1.35

References

1. Kuduk SD, Chang RK, Di Marco CN, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT..  (2010)  Quinolizidinone carboxylic acids as CNS penetrant, selective m1 allosteric muscarinic receptor modulators.,  1  (6): [PMID:24900206] [10.1021/ml100095k]

Source

Source(1):

• Scientific Literature